| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,812 |
11,773 |
$672K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,367 |
11,328 |
$472K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,347 |
2,332 |
$394K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
11,298 |
6,080 |
$319K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,973 |
3,257 |
$215K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,876 |
3,552 |
$84K |
| 0240U |
|
692 |
540 |
$80K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,226 |
2,948 |
$72K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,520 |
1,317 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,496 |
2,177 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,893 |
2,893 |
$39K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
252 |
105 |
$34K |
| 99497 |
|
790 |
621 |
$29K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
263 |
224 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
363 |
316 |
$10K |
| 93000 |
|
1,011 |
748 |
$10K |
| 96160 |
|
838 |
703 |
$9K |
| 99354 |
|
192 |
129 |
$5K |
| 81025 |
|
964 |
752 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
902 |
724 |
$5K |
| 99215 |
Prolong outpt/office vis |
101 |
73 |
$5K |
| 92552 |
|
278 |
251 |
$4K |
| 96127 |
|
1,259 |
1,052 |
$4K |
| 81003 |
|
2,729 |
2,132 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
55 |
42 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
333 |
257 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
59 |
47 |
$3K |
| 80305 |
|
500 |
394 |
$3K |
| 96136 |
|
135 |
106 |
$3K |
| 82962 |
|
1,359 |
1,014 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
191 |
145 |
$2K |
| 99442 |
|
111 |
82 |
$2K |
| 87631 |
|
14 |
13 |
$2K |
| 99401 |
|
97 |
78 |
$2K |
| 99402 |
|
33 |
32 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
63 |
52 |
$1K |
| 96103 |
|
82 |
57 |
$1K |
| 99173 |
|
204 |
184 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
14 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,018 |
825 |
$967.37 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
15 |
15 |
$912.26 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
60 |
45 |
$849.13 |
| 99406 |
|
172 |
108 |
$755.37 |
| 96120 |
|
27 |
22 |
$648.12 |
| 90674 |
|
46 |
28 |
$568.72 |
| 0002A |
|
14 |
12 |
$499.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,284 |
1,039 |
$474.27 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
286 |
220 |
$411.06 |
| 82947 |
|
191 |
135 |
$363.23 |
| 0001A |
|
15 |
14 |
$360.00 |
| 36415 |
Collection of venous blood by venipuncture |
199 |
167 |
$336.61 |
| 99441 |
|
18 |
17 |
$245.79 |
| H0049 |
Alcohol and/or drug screening |
33 |
31 |
$202.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
39 |
26 |
$194.89 |
| 87806 |
|
19 |
13 |
$75.67 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
18 |
13 |
$46.23 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
124 |
95 |
$19.29 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
179 |
137 |
$5.67 |
| 3008F |
|
16,918 |
13,159 |
$0.04 |
| 3077F |
|
778 |
568 |
$0.02 |
| 4145F |
|
554 |
405 |
$0.02 |
| 2000F |
|
1,594 |
1,157 |
$0.02 |
| 0513F |
|
422 |
306 |
$0.02 |
| 3079F |
|
743 |
548 |
$0.02 |
| 3078F |
|
790 |
580 |
$0.00 |
| 1158F |
|
147 |
101 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
378 |
306 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
256 |
199 |
$0.00 |
| 1124F |
|
455 |
349 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
80 |
66 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
87 |
78 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
261 |
217 |
$0.00 |
| G9287 |
Antibiotic regimen not prescribed within 10 days after onset of symptoms |
84 |
73 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
13 |
12 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
15 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
265 |
219 |
$0.00 |
| 3080F |
|
191 |
140 |
$0.00 |
| 3074F |
|
806 |
605 |
$0.00 |
| 4050F |
|
1,111 |
806 |
$0.00 |
| 3075F |
|
153 |
127 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
276 |
229 |
$0.00 |
| 3048F |
|
17 |
15 |
$0.00 |
| G9459 |
Currently a tobacco non-user |
32 |
27 |
$0.00 |
| G9313 |
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason |
49 |
43 |
$0.00 |